72F fusion protein is a candidate tuberculosis vaccine created by Statens Serum Institut (SSI). The 72F fusion protein is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.
Read article at Wikipedia
72F fusion protein
Medicine
Infectious Disease:
We can also tell you 72F fusion protein is a
If you know more about 72F fusion protein, you can add more facts here »
Similar topics in Freebase
-
Flu vaccine
The influenza vaccine is an annual vaccine to protect against the highly variable influenza virus. Each injected seasonal influenza vaccine contains three influenza viruses: one A (H3N2) virus, one regular seasonal A (H1N1) virus (not the 2009 pandemic H1N1 virus), and one B virus. "Influenza... -
MMR vaccine
The MMR vaccine is a mixture of three live attenuated viruses, administered via injection for immunization against measles, mumps and rubella (also called German measles). It is generally administered to children around the age of one year, with a second dose before starting school (i.e. age 4/5).... -
Hepatitis A vaccine
Hepatitis A Vaccine, (brand names include Havrix or Avaxim), is a vaccine against the Hepatitis A virus. The vaccine protects against the virus in more than 95% of cases and provides protection from the virus for at least ten years. The vaccine contains inactivated Hepatitis A virus providing... -
MVA85A
MVA85A (modified vaccinia Ankara 85A) is a new-generation vaccine against tuberculosis developed by researchers at Oxford University. This vaccine produces higher levels of long-lasting cellular immunity when used together with the old TB vaccine called BCG. Phase I clinical trials have been... -
Plague vaccine
Plague vaccine is a vaccine used against Yersinia pestis. -
DPT vaccine
DPT (also DTP and DTwP) refers to a class of combination vaccines against three infectious diseases in humans: diphtheria, pertussis (whooping cough) and tetanus. The vaccine components include diphtheria and tetanus toxoids, and killed whole cells of the organism that causes pertussis (wP). DTaP ... -
RBCG30
rBCG30 (recombinant Bacillus Calmette-Guérin 30) is a prospective vaccine against tuberculosis created by a team headed by Marcus A. Horwitz at UCLA. It is a live vaccine, consisting of BCG genetically modified to produce abundant amounts of a 30kDa antigen that has been shown to produce a strong... -
Varicella vaccine
The varicella vaccine is a live (attenuated) vaccine that protects against the viral disease commonly known as chickenpox. Chickenpox is most often a mild disease, especially for children. Prior to the introduction of vaccine in 1995 in the US (released in 1988 in Japan & Korea), there were around...